ecancermedicalscience

Research

Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer

23 May 2022
Daniel Canteros, Benjamín Walbaum, Miguel Cordova-Delgado, Andrés Torrealba, Constanza Reyes, María Elena Navarro, Dravna Razmilic, Mauricio Camus, Francisco Domínguez, Orieta Navarrete, Mauricio P Pinto, Gonzalo Pizarro, Francisco Acevedo, Cesar Sánchez

Introduction: Recently, contrast-enhanced mammography (CEM) has emerged as a reliable alternative to breast magnetic resonance imaging (MRI) for the assessment of pathological response in breast cancer patients. Our study sought to determine the diagnostic accuracy of CEM to predict pathological complete response (pCR) in patients who received neoadjuvant chemotherapy (NACT).

Methods: We retrieved the medical records of patients who underwent NACT at our institution. Using post-surgery pCR, morphological evidence and CEM enhancement tumours were classified as follows: 1) radiologic complete response (rCR); 2) functional radiological complete response (frCR); and 3) non-complete response. Initially, we used multivariate analyses adjusted by clinical variables and frCR or rCR to determine which variables affected pathological response. Then, CEM diagnostic accuracy to discriminate pCR was assessed using receiver operating characteristic curves in univariate and multivariate models including either frCR or rCR.

Results: A total of 48 patients were included in our study. Most patients (68.7%) were hormone receptor (HR)+ and 41.6% (20) of the patients achieved pCR. Using univariate logistic regression analyses we found that HR status, HER2 status, rCR and frCR had a significant impact on CEM diagnostic accuracy. Exploratory analyses found that CEM sensitivity was higher for HR− tumours. Multivariate logistic regression analyses found 60% sensitivity, 92.9% specificity and 79.2% accuracy in a model that included clinical variables and rCR.

Conclusion: CEM is a reliable alternative to high-cost, time-consuming breast MRI that predicts pCR in patients undergoing NACT; CEM diagnostic accuracy was higher among patients who harboured HR− tumours.

Related Articles

Sharif Adeniyi Folorunso, Atara Ntekim, Abbas Adesina Abdus-salam, Adeniyi Olabumuyi, Aminat Omolara Folorunso, Festus Igbinoba, Adeniyi Abidemi Adenipekun
Yasmim Portela Machado de Aguiar, Adjanny Estela Santos de Souza, Christian Diniz Lima e Silva, Sândrea Ozane do Carmo Queiroz
Yumna Ahmed, Agha Muhammad Hammad Khan, Fatima Shaukat, Rabia Tahseen, Maria Tariq, Bilal Mazhar, Sehrish Abrar, Nasir Ali
Sanjit Kumar Agrawal, Himanshu Sharma, Noopur Priya, Anoop P Saji, Hamyung Denchu Phom, Abhishek Sharma, Indu Arun, Jayanta Das, Aditi Chandra, Rosina Ahmed
Sanjit Kumar Agrawal, Piyush Ranjan, Noopur Priya, Shashank Nigam, Sumohan Chatterjee